Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 18.41 USD 0.6% Market Closed
Market Cap: 201.4m USD
Have any thoughts about
Medifast Inc?
Write Note

Wall Street
Price Targets

MED Price Targets Summary
Medifast Inc

Wall Street analysts forecast MED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 16.83 USD with a low forecast of 16.16 USD and a high forecast of 17.85 USD.

Lowest
Price Target
16.16 USD
12% Downside
Average
Price Target
16.83 USD
9% Downside
Highest
Price Target
17.85 USD
3% Downside

MED Last Price Targets
Medifast Inc

The latest public price target was made on Nov 5, 2024 by Linda Bolton Weiser from D.A. Davidson , who expects MED stock to drop by 8% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Linda Bolton Weiser
D.A. Davidson
17 USD
Downside 8%
2 weeks ago
Nov 5, 2024
DA Davidson Upgrades Medifast (MED) to Neutral
StreetInsider
Linda Bolton Weiser
D.A. Davidson
17.5 USD
Downside 5%
5 months ago
Jun 5, 2024
DA Davidson Downgrades Medifast (MED) to Underperform
StreetInsider
Linda Bolton Weiser
D.A. Davidson
25 USD
Upside 36%
6 months ago
Apr 30, 2024
Medifast (MED) PT Lowered to $25 at DA Davidson
StreetInsider
Stephanie Wissink
Jefferies
150 USD
Upside 715%
1 year ago
Jun 5, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields
Benzinga
Linda Bolton Weiser
D.A. Davidson
94 USD
Upside 411%
1 year ago
Apr 6, 2023
Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts
Benzinga
Linda Bolton Weiser
D.A. Davidson
Price Target 17 USD
Upside/Downside 8%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 17.5 USD
Upside/Downside 5%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 25 USD
Upside/Downside 36%
View Source
Stephanie Wissink
Jefferies
Price Target 150 USD
Upside/Downside 715%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 94 USD
Upside/Downside 411%
View Source
Medifast Inc Competitors:
Price Targets
W7L
Warpaint London PLC
23% Upside
1707
Grape King Bio Ltd
11% Upside
4190
Jourdeness Group Ltd
170% Upside
4931
Shinnihonseiyaku Co Ltd
2% Downside
2931
Euglena Co Ltd
41% Upside
LFMD
LifeMD Inc
124% Upside
300957
Yunnan Botanee Bio-Technology Group Co Ltd
27% Upside
301108
Tongling Jieya Biologic Technology Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Medifast Inc

For the last 8 years the compound annual growth rate for Medifast Inc's revenue is 19%. The projected CAGR for the next 3 years is -22%.

19%
Past Growth
-22%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medifast Inc

For the last 8 years the compound annual growth rate for Medifast Inc's operating income is 20%. The projected CAGR for the next 2 years is -80%.

20%
Past Growth
-80%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Medifast Inc

For the last 8 years the compound annual growth rate for Medifast Inc's net income is 22%. The projected CAGR for the next 3 years is -62%.

22%
Past Growth
-62%
Estimated Growth
Estimates Accuracy
7%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MED's stock price target?
Price Target
16.83 USD

According to Wall Street analysts, the average 1-year price target for MED is 16.83 USD with a low forecast of 16.16 USD and a high forecast of 17.85 USD.

What is Medifast Inc's Revenue forecast?
Projected CAGR
-22%

For the last 8 years the compound annual growth rate for Medifast Inc's revenue is 19%. The projected CAGR for the next 3 years is -22%.

What is Medifast Inc's Operating Income forecast?
Projected CAGR
-80%

For the last 8 years the compound annual growth rate for Medifast Inc's operating income is 20%. The projected CAGR for the next 2 years is -80%.

What is Medifast Inc's Net Income forecast?
Projected CAGR
-62%

For the last 8 years the compound annual growth rate for Medifast Inc's net income is 22%. The projected CAGR for the next 3 years is -62%.

Back to Top